Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern Tohoku General Hospital is a premier medical institution based in Koriyama, Japan, and serves as the flagship facility of the Minami Tohoku Group. It is globally recognized for establishing the world's first hospital-based Boron Neutron Capture Therapy (BNCT) center, a revolutionary precision radiation treatment for cancer. The hospital integrates advanced clinical care with high-level research through its affiliated Southern Tohoku Research Institute for Neuroscience. Its specialized services include oncology, neurosurgery, and cardiovascular medicine, supported by cutting-edge diagnostic technologies such as PET-CT and proton beam therapy. The institution is a key player in the clinical development and commercial application of nuclear medicine in East Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southern Tohoku Hospital.